alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

**CERTIFICATIONS PURSUANT TORULE 13a-14(b) UNDER THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350**

In connection with the Annual Report of North AmericanScientific, Inc. (“Company”) on Form 10-K for the year ending October 31,2005, as filed with the Securities and Exchange Commission on the date hereof(the “Report”), L. Michael Cutrer, President and Chief Executive Officer of theCompany and, James W. Klingler, Senior Vice President and Chief FinancialOfficer of the Company, certify, to the best of our knowledge, pursuant to Rule 13a-14(b) underthe Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)          The Report fullycomplies with the requirements of section 13(a) or 15(d) of theSecurities Exchange of 1934; and

(2)          Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

| Date: January 17, 2006  | By:    | /s/ L. MICHAEL  CUTRER                     |
|------------------------------|--------|--------------------------------------------|
|                         |   | L. Michael Cutrer*Chief Executive Officer* |
| Date: January 17,  2006 | By:    | /s/ JAMES W. KLINGLER                      |
|                         |   | James W. Klingler*Chief Financial Officer* |

 

----
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2407 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2407

         To reduce temporarily the duty on lithium carbonates.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 29, 2009

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
         To reduce temporarily the duty on lithium carbonates.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LITHIUM CARBONATES.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Lithium carbonates  2.3%         No change        No change        On or before 12/  ''.
                        (provided for in                                                   31/2011.......
                        subheading
                        2836.91.00)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of enactment of this Act.
                                 <all>
```
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of BigString Corporation (the
"Company") on Form 10-QSB for the period ended September 30, 2007 (the
"Report"), I, Darin M. Myman, President and Chief Executive Officer of the
Company, do hereby certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant
to ss.906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)  the Report fully complies with the requirements of ss.13(a) or 15(d) of the
     Securities Exchange Act of 1934, 15 U.S.C. ss.78m or 78o(d), and,

(2)  the information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.

Dated: November 14, 2007                   /s/ Darin M. Myman
                                           -------------------------------------
                                           Darin M. Myman
                                           President and Chief Executive Officer
## In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02

- 18

- 00446

- CR

V INCENT L EE S EAMAN

, Appellant

V

.

T HE S TATE OF T EXAS §

§

§

§

§ On Appeal from the 372nd District

Court

of Tarra nt County (1491876W)

January 23, 2020

Opinion by Chief Justice Sudderth

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that there

was no error in the trial court’s judgment. It is ordered that the judgment of th e trial

court is affirmed.

SECOND DISTRICT COURT OF APPEALS

By

__ /s/ Bonnie Sudderth

________________ Chief Justice Bonnie Suddert h
Opinion issued December 10, 2013

In The 

## Court of Appeals For The 

## First District of Texas

———————————— NO. 01
- 13
- 00644
- CV

——————————— WILLIAM COOK , Appellant

V. US BANK NA AS TRUSTEE FOR ASSET BACKED SECURITIES CORPORATION HOME EQUITY LOAN TRUST SERIES OOMC 2006 HE5 ASSETT BACKED PASS THROUGH CERTIFICATES SERIES

OOMC 2006 HE5 , Appellee

On Appeal from the County Court at Law No. 4 and Probate Court of

Brazoria County, Texas Trial Court Ca se No. CI049170

MEMORANDUM OPINION Appellant , William Cook , has neither paid the required fees nor established indigence for purposes of appellate costs. See T EX
. R. A PP
. P. 5, 20.1 ; see also2

T EX
. G OV ’ T C ODE A NN
. § § 51.207, 51.941(a), 101.041 ( West 201 3 ); Order Regarding Fees Charged in Civil Cases in the Suprem e Court and the Courts of Appeals and Before the Judicial Panel on Multidistrict Litigation, Misc. Docket No. 07

- 9138 (Tex. Aug. 28, 2007), reprinted in T EX
. R. A PP
. P . app. A § B(1)

. Further, Cook has not paid or made arrangements to pay the fee for prep aring the clerk’s record. See T EX
. R. A PP
. P. 37.3(b)

. After being notified that this appeal was subject to dismissal, appellant did not adequately respond. See T EX
. R. A PP
. P. 5 ; 42.3 (b), (c). We dismiss the appeal for nonpayment of all required fees and for want of prosecution . We dismiss any pending motions as moot. PER CURIAM

Panel consists of Justices Jennings, Sharp, and Brown.
Exhibit 10.39

AMENDMENT

This Amendment to Secured Promissory Notes, dated as of March 31, 2009 (this Amendment) is executed by White Star, LLC, Mueller Trading, L.P.,   Jason Lyons, an individual and SRZ Trading, LLC  (collectively, the Lenders), for the purposes set forth herein.

RECITALS

(a)

The Lenders and VOYANT INTERNATIONAL CORPORATION, a Nevada corporation (the Borrower) are parties to a certain Secured Promissory Notes, each dated January 26, 2009 (the Notes).

(b)

The Borrower has requested that the Lenders extend the Maturity Date as defined in the Notes in order to allow the Borrower additional time to satisfy the requirements of such sections of the Notes.

NOW, THEREFORE, the Lenders hereby agree as follows:

ARTICLE I

AMENDMENT

1.1

Amendment.  Subject to the terms and provisions of this Amendment, the Lenders hereby agree that for purposes of the Notes, the defined term Maturity Date shall be amended to October 13, 2009.

1.2

Limited Nature of Amendment. This Amendment is specifically limited to the matters expressly addressed herein.  This Amendment does not constitute a waiver, amendment, or forbearance of, or with respect to, any other or additional event, circumstance, default or event of default that may now exist or that may hereafter occur under, or in connection with, the Notes or the Security Agreement.   Except as specifically set forth herein, all of the terms and conditions of the Notes and the Security Agreement remain unchanged and in full force and effect.



[SIGNATURE PAGES FOLLOW]



513022.000004 DALLAS 2463944.1



---



|               | 
|-------------- | 
|White Star LLC
|               | 
|               | 
|By:            | 
|Name:
Title:   | 



|                | 
|--------------- | 
|SRZ Trading LLC
|                | 
|                | 
|By:             | 
|Name:
Title:    | 



|                    |            
|------------------- | -----------
|MUELLER TRADING L.P
|                    |            
|                    |            
|By:                 |            
|Name:
Title:        |            
|                    |            
|                    |            
|                    |            
|                    | Jason Lyons





513022.000004 DALLAS 2463944.1
II 

111TH CONGRESS 

1ST SESSION S. 2432 

To extend the temporary suspension of duty on certain children’s footwear. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mr. BROWNBACK introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on certain 

children’s footwear. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN CHILDREN’S FOOTWEAR. 

4 (a) IN GENERAL.—Heading 9902.22.46 of the Har5 monized Tariff Schedule of the United States (relating to 

6 certain children’s footwear) is amended by striking ‘‘12/ 

7 31/2009’’ and inserting ‘‘12/31/2011’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


jbell on DSKDVH8Z91PROD with BILLS
2 

•S 2432 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
**Exhibit 31.1**

**CERTIFICATION OFCHIEF EXECUTIVE OFFICER**

I, L. MichaelCutrer, certify that:

1.                 I have reviewedthis annual report on Form 10-K of North American Scientific, Inc.;

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                 The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

a)               Designed suchdisclosure controls and procedures, or caused such disclosure controlprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

b)              Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)               Disclosed in thisreport any changes in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.                 The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of registrant’s board of directors (or personsperforming the equivalent functions):

a)               All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

b)              Any fraud, whetheror not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.

Date: March 11,2005
| /s/ L. MICHAEL CUTRER                    | * * |
|------------------------------------------|----------|
| L. Michael Cutrer                        | * * |
| *President  and Chief Executive Officer* | * * |

 

1

----
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 27, 2012, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug
Schedule4-methyl-N-methylcathinone (1248)
IGamma Hydroxybutyric Acid (2010)
IMescaline (7381)
IN-Benzylpiperazine (7493)
I3,4-methylenedioxypyrovalerone (7535)
I3,4-methylenedioxy-N-methylcathinone (7540)
I
 The company plans to manufacture the above listed controlled substances to supply these materials to the research and forensics community for drug testing and analysis. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 21, 2012. Dated: March 8, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2012-6705 Filed 3-19-12; 8:45 am] BILLING CODE 4410-09-P
<PAGE>
                                                                    EXHIBIT 99.2

     CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         This certification is provided pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and accompanies the annual report on Form 10-KSB (the
"Form 10-KSB") for the year ended September 30, 2002 of Probex Corp. (the
"Issuer"). The undersigned hereby certifies that, to the best of my knowledge,
the Form 10-KSB fully complies with the requirements of section 13(a) or section
15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78(o)(d)) and
that the information contained in the Form 10-KSB fairly presents, in all
material respects, the financial condition and results of operations of the
Issuer.

Dated:   December 26, 2002

By:      /s/ Bruce A. Hall
         -----------------
Name:    Bruce A. Hall
Title:   Senior Vice President, Chief Financial Officer and Secretary
EXHIBIT 32-2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report on Form 10-K of WNC California Housing
Tax Credits, L.P. (the "Partnership") for the year ended March 31, 2006 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
and pursuant to 18 U.S.C.,  section 1350, as adopted  pursuant to section 906 of
the  Sarbanes-Oxley  Act of 2002, I, Thomas J. Riha, Chief Financial  Officer of
WNC & Associates, Inc., general partner of the Partnership, hereby certify that:

     1.   The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the  Securities  Exchange  Act of 1934, and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Partnership.




/s/THOMAS J. RIHA
-----------------
Thomas J. Riha
Senior Vice President and Chief Financial Officer of WNC & Associates, Inc.

Date:  August 31, 2006
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

In the Matter of the

ESTATE OF GLORIA IRMA

MARQUEZ. §

§

§

§

§

§ No. 08

- 1 9

- 00303

- CV

Appeal from the

Probate Court No. 2

of El Paso County, Texas

(TC# 2019CPR01456 )

J U D G M E N T

The Court has considered this cause on the record and concludes the attempted appeal

should be dismissed for want of jurisdiction, in accordance with the opinion of this Court. We

therefore dismiss th e appeal. We further order Appellant pay all costs of this appeal and this

decision shall be certified below for observance.

IT IS SO ORDERED THIS 24TH DAY OF JANAURY, 2020.

YVONNE T. RODRIGUEZ, Justi ce

Before Alley, C.J., Rodriguez, and Palafox, JJ.
II 

111TH CONGRESS 

1ST SESSION S. 2154 

To suspend temporarily the duty on dodecyltrimethylammonium bromide. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mr. SPECTER (for himself and Mr. CASEY) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on 

dodecyltrimethylammonium bromide. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DODECYLTRIMETHYLAMMONIUM BROMIDE. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Dodecyltrimethylammonium 

bromide (CAS No. 1119–94– 

4) (provided for in subheading 2923.90.00) ............. Free No change No change On or before 

12/31/2011 ’’. 


tjames on DSKG8SOYB1PROD with BILLS
2 

•S 2154 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS
Exhibit 10.37
 AMENDMENT NO. 1 TO
AMENDED AND RESTATED LICENSE AGREEMENT
 THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT
 WHEREAS
 AND WHEREAS
 NOW, THEREFORE,
 ARTICLE 1
DEFINITIONS
  ARTICLE 2
AMENDMENT OF RESTATED AGREEMENT
 2.1 Amendment re Section 5.3.2.
 5.3.2
 *
    
    Certain information in this exhibit has been omitted as confidential, as indicated by [***].
This information has been filed separately with the Commission.




---



##### 



2.2 Amendment re Section 6.5.
 (a)
 2.3 Addition of Section 6.11
 provided
 2.4 Amendment re Section 7.2. 2(b) .
 (b)
 2.5 Addition of Section 7.2.2(c)
 (b)
 2.6 Amendment re Section 8.3. 1(a) .




---



##### 



2.7 Amendment re Section 9.3.1.
 2.8 Amendment re Section 12.2.1.
 12.2.1 Failure to Pay.
 2.9 Amendment re Section 12.2.2.
 12.2.2 Discontinued Development.
 (a) provided that




---



##### 



(b) provided, however
 (c)
 2.10 Addition of Section 12.2.3
 12.2.3
 2.11 Amendment re Section 13.15.
 13.15.7




---



##### 



2.12 Amendment re Appendix A.
 Discontinuance
 2.13 Amendment re Appendix A.
 Revenue
 2.14
 ARTICLE 3
REPRESENTATIONS AND COVENANTS RELATING TO AMENDMENT OF RESTATED AGREEMENT
 3.1 Representations and Covenants Regarding Improvements and Technology.




---



##### 



3.2 Representations and Covenants Regarding Agreements.
 ARTICLE 4
MISCELLANEOUS
 4.1 Integration.
 4.2
 4.3




---



##### 



IN WITNESS WHEREOF,
 OncoGenex Technologies Inc.
    
    ISIS Pharmaceuticals, Inc.Per:
    
    /s/ Scott Cormack
    
    Per:
    
    /s/ B. Lynne ParshallScott D. Cormack,
    
    B. Lynne ParshallPresident & CEO
    
    COO and CFO
#### In the Matter of Victoria A. PHILLIPS v. HAMILTON-MEDICAL GROUP, et al. In the Matter of Victoria A. PHILLIPS v. Dr. Cary HERNANDEZ.

No. 87-C-1451.

Supreme Court of Louisiana.

Sept. 25, 1987.

In re Phillips, Victoria A.; applying for writ of certiorari and/or review; to the Court of Appeal, Third Circuit, Nos. CA86-0598, CA86-0599; Parish of Lafayette, 15th Judicial District Court, Div. “G”, Nos. 856936, 857612.

Prior report: La.App., 507 So.2d 277.

Denied.
SUPREME COURT 

OF 

NEVADA 

IN THE SUPREME COURT OF THE STATE OF NEVADA 

DENTS ASTARITA, M.D., 

Petitioner, 

vs. 

THE SECOND JUDICIAL DISTRICT 

COURT OF THE STATE OF NEVADA, 

IN AND FOR THE COUNTY OF 

WASHOE; AND THE HONORABLE 

DAVID A. HARDY, DISTRICT JUDGE, 

Respondents, 

and 

REBECCA KOSAK; AND MARK 

KOSAK, 

Real Parties in Interest. 

No. 67186 

FILED 

MAR 2 5 2016 

TRACE K. LINDEMAN 

CLERK OF 41.1PREME COURT 

PU 

ay SD '

ORDER DENYING PETITION FOR WRIT OF MANDAMUS OR 

PROHIBITION 

This is an original petition for a writ of mandamus or 

prohibition challenging a district court order denying a motion to dismiss 

in a medical malpractice action. 1 

Petitioner argues that the district court erred in denying the 

motion to dismiss and allowing amendment instead when the court found 

that the complaint and affidavit were deficient. 

Writ relief is generally not available when a petitioner has an 

adequate remedy at law, such as an appeal from a final judgment. See 

NRS 34.170; NRS 34.330; Pan v. Eighth Judicial Dist. Court, 120 Nev. 

222, 224-25, 88 P.3d 840, 841 (2004). Having considered the documents 

1The Honorable James W. Hardesty, Justice, voluntarily recused 

himself from participation in the decision of this matter. 

10) 1947A e IG -Oqq5.1 
and arguments presented in this matter, we conclude that our 

extraordinary intervention is not warranted. See Pan, 120 Nev. at 228, 88 

P.3d at 844 (providing that petitioner bears the burden of showing writ 

relief is appropriate). Accordingly, we 

ORDER the petition DENIED. 

2000....2r 

Parraguirre 

C.J. 

, J. 

Pickering 

SUPREME COURT 

OF 

NEVADA 

2 

(0) 01,17A 
cc: Hon. David A. Hardy, District Judge 

Lemons, Grundy & Eisenberg 

Stephen H. Osborne 

Washoe District Court Clerk 

SUPREME COURT 

OF 

NEVADA 

3 

1947A e
#### Reginald FENCHER, Appellant, v. STATE of Florida, Appellee.

No. 87-1133.

District Court of Appeal of Florida, First District.

June 8, 1988.

Reginald Fencher, pro se.

Robert A. Butterworth, Atty. Gen., and William A. Hatch, Asst. Atty. Gen., Tallahassee, for appellee.

PER CURIAM.

AFFIRMED. *See Demps v. State,*515 So.2d 196 (Fla.1987); *Grooms v. State,*522 So.2d 445 (Fla. 1st DCA 1988).

SMITH, C.J., and JOANOS and ZEHMER, JJ., concur.